Tanfac Industries Ltd Q3 FY26: ₹173 Cr Revenue, PAT Slips 55% QoQ, ROCE Still a Scary 42% – Chemistry Ka Topper or Valuation Ka Overachiever?
1. At a Glance – Blink and You’ll Miss the Fluorine
Market cap ₹4,034 Cr. Stock at ₹4,044. Three-month return +3.9%, six-month return -8.2%. ROCE 41.8% and ROE 32% scream “capital efficiency”, while P/E 53.9x whispers “valuation ka practical exam chal raha hai.” Latest Q3 FY26 results show Revenue ₹173 Cr, PAT ₹15.6 Cr, with profit down 55% QoQ (yes, that hurt). Debt is pocket-change (₹31.5 Cr, D/E 0.09). Dividend yield 0.22%—don’t quit your job for that.
But here’s the masala: brownfield HF expansion done, solar-grade DHF commissioned, multi-year Japanese contracts signed, and forward integration plans cooking. Question is simple—is the chemistry still reacting, or has valuation evaporated the solvent?
2. Introduction – Fluorine, Fame, and a Few Fumes
Founded in 1972, Tanfac sits quietly in SIPCOT, Cuddalore, making chemicals that are dangerous enough to scare amateurs and profitable enough to excite veterans. Hydrofluoric Acid (HF) isn’t a college lab experiment; it’s hardcore industrial chemistry.
The stock has delivered 83% CAGR over 5 years, which explains the premium multiple. But Q3 FY26 slapped investors with a reality check—margins cooled, profits dipped, and the market asked: “Boss, growth story pause pe hai kya?”
Meanwhile, promoters include Tamil Nadu Industrial Development Corporation and Anupam Rasayan India Limited—a PSU-private combo that’s rare, stable, and occasionally bureaucratic. With fresh capex, QIP plans, and long-term contracts starting H2 FY26 onwards, this story is less about one quarter and more about execution vs expectations.
So… do you trust chemistry, or do you fear valuations? 🤔
3. Business Model – WTF Do They Even Do?
Think of Tanfac as the HF supermarket. They manufacture Anhydrous Hydrofluoric Acid, Aluminium Fluoride, sulphuric acid, oleum, specialty fluorides, and now solar-grade diluted HF.
HF is the mother molecule. From aluminium smelting to refrigerant gases, glass etching to lithium-ion batteries—HF is everywhere, quietly burning margins (the good kind).
82% domestic, 18% exports to USA, Japan, South Korea, UAE etc. Over 300 customers, long-term contracts, and tech tie-ups with Davy (Switzerland) and CHENCO (Germany).
Forward integration is the real plot twist—moving from commodity HF to value-added fluorinated chemicals. That’s where margins bulk up. That’s also where execution risk lives rent-free.
Simple question: Can Tanfac climb the value chain without tripping over capex and timelines?
4. Financials Overview – Numbers Don’t Lie, They Roast
Result Type Locked:Quarterly Results (Q3 FY26). EPS Annualisation Rule Applied: Q3 → average of Q1, Q2, Q3 × 4.
Quarterly Comparison (₹ Cr)
Source table
Metric
Latest Q3 FY26
YoY Q3 FY25
Prev Q2 FY26
YoY %
QoQ %
Revenue
173
88
169
+96%
+2%
EBITDA
26
15
27
+73%
-4%
PAT
15.6
10
17
+56%
-55%
EPS (₹)
15.61
10.11
17.22
+54%
-9%
Commentary: Revenue strong, margins wobbling, PAT slipped like a banana peel. One quarter doesn’t kill the story—but at 53.9x P/E, market expects Michelin-star consistency, not dhaba surprises.
